Dr. Deborah M. Axelrod, MD

Dr. Axelrod practices at NYU Langone Perlmutter Cancer Center - 34th St in New York, New York.

Dr. Axelrod's NPI, 1386644573, was assigned on July 28, 2005. Dr. Axelrod graduated from Tel Aviv University Sackler in 1982. Dr. Axelrod holds New York license 151859.

Dr. Axelrod's primary practice is NYU Langone Perlmutter Cancer Center - 34th St, at 14 Wall St, New York, NY 10005 in New York County. The practice phone is (212) 263-1481.

Dr. Axelrod's primary practice is NYU Langone Perlmutter Cancer Center - 34th St in New York, New York. Dr. Axelrod is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Axelrod to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Axelrod practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Axelrod's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Axelrod is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Axelrod's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists breast reconstruction, breast surgery and mastectomy among the conditions Dr. Axelrod treats.

CMS data shows 1,048 Medicare services from Dr. Axelrod across 11 procedure codes in 2024, for 628 Medicare patients. Medicare paid $141,021 for them.

CMS counts 628 Medicare patients who saw Dr. Axelrod in 2024. The largest group is 65 to 74, with 296 patients. 75% of them have cancer, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Axelrod's median patient age at 67, with 95% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Axelrod for performance year 2024, reported as part of a group. Dr. Axelrod accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 79 procedures of mastectomy by Dr. Axelrod, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 114 papers to Dr. Axelrod, published from 2004 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Breast Neoplasms, Carcinoma, Ductal, Breast and Mastectomy. Dr. Axelrod has published most often in Ann Surg Oncol. Dr. Axelrod's most frequent co-authors are Freya R. Schnabel, MD, Nolan S. Karp, MD and Yao Wang, MD.

Dmand AI links Dr. Axelrod to 2 clinical trials. Conditions studied include Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ. NYU Langone Health sponsors the most, 2.

CMS Open Payments shows 10 general payments to Dr. Axelrod from 4 drug and device companies from 2023 to 2025. Travel and lodging make up the largest share, 62% of the total. AxoGen paid the most, $2,254.

Dmand AI lists 2 awards for Dr. Axelrod, most recently CMS Stage 1 EHR in 2013.

Dr. Axelrod graduated from Tel Aviv University Sackler in 1982.

Dr. Axelrod is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.